top of page
Search

Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea

  • Writer: S-Med
    S-Med
  • Jun 21, 2023
  • 1 min read

Unilateral transvenous PNS with Remedē System in patients with CSA is associated with a high response to therapy through 36 months follow-up as well as echocardiography parameters through 24 months. The benefits appear to be sustained with no safety concerns.




 
 
 

Comentários


bottom of page